Introduction
Of the important analytes which need to be commonly assayed, the 'trace metabolites' constitute an important category, since under this heading are included drugs and their metabolites, steroids and hormones. These analytes are commonly present at nanomolar or lower levels in complex biological matrices such as serum and synovial fluid. They generally exhibit potent biological activity or are metabolized to compounds which exhibit such activity, and other concomitant processes in vivo may induce wide fluctuations in their levels. Methods for their analysis should therefore have the appropriate sensitivity and be responsive to such changes in concentrations in vivo. Examples of current analytical methods include immunoassay and chromatographic methods such as h.p.1.c. and gas chromatography, the latter two often linked to mass spectrometry to achieve the sensitivity needed to detect these analytes in biological fluids. None of these methods has the capacity to respond to the needs of the analyst listed above, although as a compromise the methods are able to process large numbers of samples, through automation, in specialist laboratories away from the patient. A large capital investment is required to establish and run such facilities.
The ideal method for analysis of trace metabolites within patients is therefore one which can detect, in real time, changes in analyte levels within the biological matrix in which the metabolite's activity is expressed.
The body has, of course, developed such a detection system for these analytes. This resides in the metabolite-receptor interaction produced when the metabolite docks with its specific receptor in vivo. The consequence of such a docking process is the induction of a signal which precipitates a qhysiological change in the system. This is the case for all hormones and steroids and for many drugs since their biological activities stem from such receptor-ligand (analyte) interactions.
Attention has therefore centred on the ability to recreate this in vivo interaction process in vitro
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and much effort has been spent on isolating biological receptors, purifying them, reconstituting them, and investigating their properties, primarily as a means to investigate the mechanism of action of such receptors but also, as a spin-off, as analytical devices. 
Candidate receptors and their binding ligands

Structure and function of membranebound receptors
With the exception of steroid receptors, the receptors listed above are membrane-associated proteins.
Binding of specific ligands to the receptor, which is located on the outer surface of the membrane, gives rise to a conformational change in the protein that results in a signal passing across the membrane which in turn induces a physicochemical change on the interior surface of the membrane [ 3 ] . Receptors are classified according to the manner in which the signal resulting from the outer docking event is transmitted to the inner surface. The three main types of receptors are the ligand-gated ion channels, voltage-gated ion channels and receptors and Gprotein-coupled receptors [ 11. All three types exist as polymeric subunits which come together to form the active unit within the membrane. Ligand-gated receptors such as the nicotinic, GARA, and glycine receptors appear to exist as pentameric substructures. The structure of the nicotinic receptor is shown in Fig. 1 
Sources of receptor material
From fresh tissue
The conventional method for isolating receptors is to extract them from fresh tissue which is known to be rich in the required receptor. The tissue or organ is homogenized over ice and then centrifuged. The resulting pellet contains fragments of cell membranes [ S ] . Isolation of the required receptors can then be achieved using an appropriate affinity chromatography method [6] . Typical final yields from brain tissue are in the range picomole-nanomole of receptor per mg of protein, which represents over a thousand-fold concentration of receptor during the isolation procedure although the overall yield is generally less than 25% of the receptor present in the initial homogenate. It is often found necessary to add protease enzyme inhibitors to prevent degradation of the receptors. The stability of receptor preparations depends on the receptor and its method of isolation and subsequent treatment. Membrane-associated receptors tend to be more stable than receptors resolubilized with detergents and, generally, receptors lose binding activity within hours or days at room temperature (N. Piggott & F. J. Rowell, unpublished work).
From cuhured tissue
Receptors have been harvested from cells obtained from cell culture. Thus cultures of pure neurons were isolated from cerebral cells of chick embryos after cell culture for 8 days. After cell homogenization and centrifugation, the resulting membranes were demonstrated to possess 2-4 pmol of GABA receptors per mg of total protein [7] . This approach can also be applied to cell culture of cancer cell lines which possess cell-surface receptors of interest. For example, neuroblast-glioma hybrid cells are a potential source of opioid, muscarinic and other receptors [8] .
Cloned receptors
The past decade has seen a dramatic increase in our understanding of the structure and function of membrane receptors. This has resulted from the ability to clone the DNA and genes for such receptors and to express the code in a suitable organism. This was first achieved for the nicotinic acetylcholine receptor (AChR) by Noda and his coworkers in 1984 [O] . They injected mRNAs for the receptor derived from a set of AChR clones into immature frog eggs or oocytes. The mRNAs were correctly translated and the protein subunits correctly assembled within the membrane into functioning receptors. Since that time the majority of the receptors described above have been cloned and their properties investigated [lo] . It is now possible using this approach to synthesize mutant receptors and to dissect out the structure-function relationships for these proteins. However, the concentration of receptors present in the resulting cells is still of the same order as that obtained from tissues (generally between fmol and pmol per mg of protein) and it is still necessary to isolate the receptors from the cell in order to purify and concentrate them using the .methods described above for the isolation of receptors from tissue sources.
Examples of receptor-based biosensors
Research in this area has concentrated on reconstituting isolated receptors into natural or synthetic membranes in order to demonstrate the retention of biological activity with respect to specificity of ligand binding and ion flow across the membrane resulting from the receptor-ligand binding processes. One of the earliest examples involved the nicotinic AChR isolated from the electric organ of the electric eel Torpedo culifomku. This organ was chosen since the nicotinic AChRs constitute about 50% of the total protein in membrane preparations from this source and the final concentration of AChR in such preparations is about 3 nmol/mg of protein.
The receptor was reconstituted into a sealed planar phospholipid bilayer spanning an orifice separating two buffered solutions. Electrodes were placed into the solutions above and below the bilayer and an electrical potential applied across the membrane. Changes in ion flow resulting from the addition of cholinergic compounds to 'the upper solution were monitored. In this way the ion channel opening was demonstrated to correlate with the cholinergic activity observed in vivo and with the results of ligand-binding assays using the isolated nicotinic receptor preparation [ 1 11.
Miniaturization of these cells was achieved in patch-clamp devices in which a membrane bilayer seal is formed across the tip of a glass capillary. The bilayer contains the receptors and a cell can be formed with the seal corresponding to the larger, planar bilayer used in the cell described above. Due to its smaller size (approx. 1 pm), the seal on the patch-clamp cell can contain a single channel [ 1 13. These were used in a patch-clamp device to form a single-channel test sensor and in a multi-channel test sensor. In the presence of 1.-glutamate, the ion channels were open on average for 7.6 ms during which time some 210000 sodium ions were calculated to be transported across the membrane. The multichannel sensor produced a steady-state d.c. current proportional to the concentration of 1.-glutamate over the range 50-200 pmolll [12] . In a similar fashion, olfactory membranes from the olfactory cilia of the bullfrog (Rum cutesbezizna) have been reconstituted into a planar lipid bilayer system. The cell was demonstrated to possess cation-selective ion channels which were reversibly activated by nanomolar concentrations of odorants [ 131.
The major disadvantages of the configurations described above are the inherent instability of the bilayers within the sensors (which are stable for less than a few hours) and their lack of robustness. In order to overcome these problems, two groups have investigated integrating receptors within poly- A second group have also incorporated the nicotinic AChR into a polymeric matrix and used this to coat an interdigitated gold electrode transducer [ 151. The resulting sensor is reported to respond to cholinergic ligands within 1-5 s to produce a change in impedence which is linear over the range 0.5-500 yg/ml. The biosensor is stable for at least 72 h during use and retains its activity on storage for 6 months at room temperature and in dry closed containers.
The AChR was also employed in an alternative biosensor configuration by Eldefrawi et ul. [ 161. In this case the receptor was solubilized using asolectin-cholesterol-cholate and coated on to the surface of a planar interdigitated capacitive (PIC) sensor. The capacitance of the coated sensor was observed to increase in proportion to the concentration of ACh to which it was exposed. The signal increased rapidly, peaking within 1 min, then decreasing to a stable value after 5 min. The response was specific to ACh, a range of other neurotransmitters failing to evoke a change in capacitance. The PIC sensor was described as stable but no further details were given.
Future developments
Although there is much interest in the development of biosensors in general, progress in the development of receptor-based biosensors has been slow compared to sensors based on alternative sensing and transducing systems. This is exemplified by the number of references to biosensors in 'Analytical Abstracts' for the period January 1989 to July 1990: there are 81 references of which only five refer to receptor-based systems, and of these four are based on the nicotinic AChR from T. culifoornica [14] [15] [16] [17] and the other on the 1.-glutamate receptor [ 121. The references quoted highlight the two main reasons why the greatest progress has been achieved using the nicotinic AChR from this source; it is available in reasonable quantities in purified form and is more stable than other receptor types derived from alternative sources. Developments of biosensors based on other receptor proteins therefore await sources of stable and relatively abundant receptors.
Biosensors
These may arise from cloned receptors, perhaps those derived from mutant receptors specifically designed and engineered through site-directed mutagenesis [18] , or through the synthesis of fully synthetic receptors as our knowledge of the structure-function relationships within receptors expands.
